Previous close | 2.1900 |
Open | 2.1900 |
Bid | 2.2000 x 400 |
Ask | 2.2300 x 400 |
Day's range | 2.1740 - 2.2463 |
52-week range | 2.1700 - 4.3000 |
Volume | |
Avg. volume | 467,440 |
Market cap | 219.163M |
Beta (5Y monthly) | 1.47 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Atossa (ATOS) unveils positive results from its phase 2 EVANGELINE clinical study, which shows that (Z)-endoxifen can reduce the growth of ER+ breast cancer.
In this article, we will take a look at the 13 best penny stocks to buy according to billionaire Ken Griffin. To see more such companies, go directly to 5 Best Penny Stocks to Buy According to Billionaire Ken Griffin. The markets were off to an impressive start in 2024, driven by expectations that the […]
If you love investing in stocks you're bound to buy some losers. But the long term shareholders of Accuray Incorporated...